Tatva Chintan Pharma Chem Ltd - 543321 - Closure of Trading Window
Intimation of Closure of Trading Window26-09-2023
26-09-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer''s Report / Voting Results of 27th Annual General Meeting of the Company held on Friday, 22 September 202323-09-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of proceedings of the 27th Annual General Meeting held on Friday, 22 September 202322-09-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Credit Rating21-09-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Darshana Nitinkumar Shah08-09-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Priti Ajay Patel08-09-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay Mansukhlal Patel08-09-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay Mansukhlal Patel HUF08-09-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shekhar Rasiklal Somani08-09-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Filing Of Report Under Regulation 7(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015, As Amended (''SEBI Insider Trading Regulations'')
Enclosed is the report in the format prescribed in Form B of the circular bearing number SEBI/HO/ISD/ISD/CIR/P/2021/19 dated February 9, 2021 read with the circular bearing SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/039 dated March 23,2023, issued by the Securities and Exchange Board of India.07-09-2023